$34.00
Manufacturer: Ukraine
Purpose: Antioxidant properties, treats diabetic neuropathy by improving nerve function.
Description
Dialipon (thioctic acid) ampoules 3% 10 ml. №5
Ingredients
Active ingredient: Thioctic acid 3%
Dosage
Recommended dosage: As directed by a healthcare professional.
Indications
Dialipon ampoules are indicated for the treatment of conditions where thioctic acid supplementation is necessary.
Contraindications
Do not use Dialipon ampoules if you are allergic to thioctic acid or any other ingredients in the product.
Directions
Administer Dialipon ampoules as per the healthcare provider’s instructions. It is typically administered via intramuscular or intravenous injection.
Scientific Evidence
Thioctic acid, the active ingredient in Dialipon ampoules, has been extensively studied for its antioxidant properties and potential benefits in various health conditions. Research suggests that thioctic acid may help improve insulin sensitivity, reduce inflammation, and protect against oxidative stress. Clinical trials have shown promising results in conditions such as diabetic neuropathy and liver diseases.
Additional Information
It is important to note that while thioctic acid is generally well-tolerated, some individuals may experience mild side effects such as nausea or stomach discomfort. Consult with a healthcare professional before starting any new medication or supplement regimen.
Pharmacological Effects: Thioctic acid acts as a powerful antioxidant, scavenging free radicals and helping to regenerate other antioxidants in the body. It also plays a role in energy production within cells and has anti-inflammatory properties.
Clinical Trials: Several clinical studies have investigated the efficacy of thioctic acid in various conditions. A study published in the International Journal of Endocrinology showed that thioctic acid supplementation improved symptoms of diabetic neuropathy. Another study in the European Journal of Gastroenterology & Hepatology demonstrated the potential benefits of thioctic acid in non-alcoholic fatty liver disease.
Recent Reviews